SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    R. J. Colman, D. T. Rubin, Optimal Doses of Methotrexate Combined with Anti-TNF Therapy to Maintain Clinical Remission in Inflammatory Bowel Disease, Journal of Crohn's and Colitis, 2015, 9, 4, 312

    CrossRef

  2. 2
    Fernando Gomollón, Saioa Rubio, Mara Charro, Santiago García-López, Fernando Muñoz, Javier P. Gisbert, Eugeni Domènech, Recomendaciones del Grupo Español de Trabajo de Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre el uso de metotrexato en la enfermedad inflamatoria intestinal, Gastroenterología y Hepatología, 2015, 38, 1, 24

    CrossRef

  3. 3
    Oscar Duems-Noriega, Sergio Ariño-Blasco, Subcutaneous fluid and drug delivery: safe, efficient and inexpensive, Reviews in Clinical Gerontology, 2015, 25, 02, 117

    CrossRef

  4. 4
    Brian P. Regan, Athos Bousvaros, Pediatric Ulcerative Colitis: A Practical Guide to Management, Pediatric Drugs, 2014, 16, 3, 189

    CrossRef

  5. 5
    John WD McDonald, Yongjun Wang, David J Tsoulis, John K MacDonald, Brian G Feagan, Methotrexate for induction of remission in refractory Crohn's disease, The Cochrane Library,
  6. 6
    Vishal Patel, Yongjun Wang, John K MacDonald, John WD McDonald, Nilesh Chande, Methotrexate for maintenance of remission in Crohn's disease, The Cochrane Library,
  7. 7
    Jasvinder A Singh, Shahrzad Noorbaloochi, Carter Thorne, Glen S Hazlewood, Maria E Suarez-Almazor, Elizabeth Tanjong Ghogomu, George A Wells, Peter Tugwell, Subcutaneous or intramuscular methotrexate for rheumatoid arthritis, The Cochrane Library,